|
|
|
40
|
0012EJ
|
LORATADINE 10MG TAB (KWA/ATB)
|
LORATADINE
|
LORATADINE
|
10X10
|
A
|
5.25
|
0.05
|
TABLET
|
14
|
TAB
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
0408
|
SECOND GENERATION ANTIHISTAMINES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTIHISTAMINICS
|
|
|
|
|
40
|
0111D
|
CEFUROXIME 500MG CAP (KWA/ATB)
|
CEFUROXIME
|
CEFUROXIME
|
100'S
|
BQ
|
66.95
|
0.67
|
CAPSULE
|
0
|
CAP
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
0111DL
|
CEFADROXIL 500MG CAP (KWA/ATB)
|
CEFADROXIL
|
CEFADROXIL
|
10X10
|
A
|
23.11
|
0.23
|
CAPSULE
|
28
|
CAP
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
08120604
|
FIRST GEN CEPHALOSPORINS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
0113AG
|
CEFAZOLIN 1G IV/IM INJ (KWA/ATB)
|
CEFAZOLIN
|
CEFAZOLIN
|
1G VIAL
|
B
|
4.02
|
4.02
|
INJECTION
|
0
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
08120604
|
FIRST GEN CEPHALOSPORINS
|
2022-04-01
|
2022-09-30
|
|
IV/IM
|
0
|
ANTI-INFECTIVE AGENTS
|
2022-03-30
|
|
|
|
40
|
0131CW
|
AZITHROMYCIN 40MG/ML SUSP (KWA/ATB)
|
AZITHROMYCIN
|
AZITHROMYCIN
|
15ML
|
A
|
4.76
|
0.32
|
SUSPENSION
|
30
|
ML
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
08121292
|
OTHER MACROLIDES
|
2022-04-01
|
2022-09-30
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
2022-03-30
|
|
|
|
40
|
0164AM
|
AMPICILLIN 500MG INJ (KWA/ATB)
|
AMPICILLIN
|
AMPICILLIN
|
500MG VIAL
|
BQ
|
0.90
|
0.90
|
INJECTION
|
0
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
081216
|
PENICILLINS
|
2022-04-01
|
2022-09-30
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
2022-03-30
|
|
|
|
41
|
02238
|
CLOXACILLIN 25MG/ML SUSP (KWA)
|
CLOXACILLIN
|
CLOXACILLIN
|
60ML
|
A
|
25.8241
|
0.4304
|
ML
|
300
|
BOTT
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
081216
|
PENICILLINS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
PENICILLINS
|
|
|
|
|
41
|
0294M
|
CLINDAMYCIN HCL 300MG CAP (KWA)
|
CLINDAMYCIN HCL
|
CLINDAMYCIN HCL
|
100'S
|
A
|
38.82
|
0.3882
|
CAP
|
28
|
BOX
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
08122820
|
LINCOMYCINS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
LINCOMYCINS
|
|
|
|
|
40
|
04219
|
PRIMAQUINE PHOSPHATE 15MG TAB (KWA/ATB)
|
PRIMAQUINE PHOSPHATE
|
PRIMAQUINE PHOSPHATE
|
3X10
|
A
|
40.77
|
1.36
|
TABLET
|
90
|
TAB
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
083008
|
ANTIMALARIALS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
0453D
|
CO-TRIMOXAZOLE 80MG/ML | 16MG/ML INJ (KWA/ATB)
|
SULFAMETHOXAZOLE|TRIMETHOPRIM
|
CO-TRIMOXAZOLE
|
5X5ML
|
B
|
17.67
|
3.53
|
INJECTION
|
0
|
AMP
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
081220
|
SULPHONAMIDES
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
0453D
|
CO-TRIMOXAZOLE 80MG/ML|16MG/ML INJ (KWA) SULFAMETHOXAZOLE|TR (B)
|
SULFAMETHOXAZOLE|TRIMETHOPRIM
|
CO-TRIMOXAZOLE
|
5X5ML
|
B
|
4.1
|
0.8209
|
AMP
|
20
|
BOX
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
081220
|
SULPHONAMIDES
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
SULPHONAMIDES
|
|
|
|
|
40
|
05216
|
ACTINOMYCIN D 500MCG INJ (KWA/ATB)
|
ACTINOMYCIN D
|
ACTINOMYCIN D
|
500MCG VIA
|
BQ
|
36.70
|
36.70
|
INJECTION
|
0
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
0521A
|
ACTINOMYCIN D 500MCG INJ (KWA) DACTINOMYCIN
|
DACTINOMYCIN
|
ACTINOMYCIN D
|
500MCG VIA
|
BQ
|
16.72
|
16.72
|
VIAL
|
0
|
|
KWA
|
KWALITY PHARMACEUTICALS
|
STO
|
BRYDEN STOKES LTD
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
|
Add to Contract
|
IV
|
0
|
ANTINEOPLASTICS
|
2026-03-02
|
|
|
|
41
|
0541E
|
BLEOMYCIN SULPHATE 15MG INJ (KWA) (BQ)
|
BLEOMYCIN SULPHATE
|
BLEOMYCIN SULPHATE
|
15MG VIAL
|
BQ
|
34.01
|
34.0062
|
VIAL
|
30
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
05616
|
CHLORAMBUCIL 2MG TAB (KWA/ATB)
|
CHLORAMBUCIL
|
CHLORAMBUCIL
|
3X10
|
A
|
176.69
|
5.89
|
TABLET
|
240
|
TAB
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-05-27
|
2024-03-31
|
Package Size Change
|
Oral
|
6
|
ANTINEOPLASTICS
|
2022-05-27
|
|
|
|
41
|
0575F
|
CYCLOPHOSPHAMIDE 1G INJ (KWA) (BQ)
|
CYCLOPHOSPHAMIDE
|
CYCLOPHOSPHAMIDE
|
1G VIAL
|
BQ
|
10.41
|
10.4112
|
VIAL
|
30
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
0581D
|
CYTARABINE 100MG INJ (KWA) (BQ)
|
CYTARABINE
|
CYTARABINE
|
100MG VIAL
|
BQ
|
5.55
|
5.5454
|
VIAL
|
100
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
0611C
|
MELPHALAN 2MG TAB (KWA)
|
MELPHALAN
|
MELPHALAN
|
50'S
|
A
|
83.18
|
1.6636
|
TAB
|
63
|
BOX
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
0671F
|
VINBLASTINE 10MG INJ (KWA) (BQ)
|
VINBLASTINE
|
VINBLASTINE
|
10MG VIAL
|
BQ
|
26.94
|
26.9386
|
VIAL
|
0
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
0722B
|
DEFLAZACORT 30MG TAB (KWA) (C)
|
DEFLAZACORT
|
DEFLAZACORT
|
10'S
|
C
|
13.86
|
1.3864
|
TAB
|
0
|
BOX
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
6804
|
ADRENALS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
ADRENALS
|
|